Healthcare Sector Review: Winning and Losing Stocks on Nov 23rd

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • Inhibitex, Inc. (NASDAQ:INHX): The shares closed at $11.77, up $0.99, or 9.18%, on the day. Its market capitalization is $921.51 million. About the company: Inhibitex Inc. is a biopharmaceutical company that discovers, develops, and commercializes novel antibody-based products. The Company develops products for the prevention and treatment of serious bacterial and fungal infections in the hospital setting. Get the most recent company news and stock data here >>
  • MannKind Corporation (NASDAQ:MNKD): The shares closed at $3.18, up $0.18, or 6%, on the day. Its market capitalization is $417.66 million. About the company: MannKind Corporation is a biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Companys lead investigational product candidate is the Technosphere Insulin System. Get the most recent company news and stock data here >>
  • Optimer Pharmaceuticals (NASDAQ:OPTR): The shares closed at $10.60, up $0.39, or 3.82%, on the day. Its market capitalization is $494.44 million. About the company: Optimer Pharmaceuticals, Inc. discovers, develops, and commercializes anti infective products. Optimer’s initial development efforts address products that treat gastrointestinal infections (GI), and related diseases, including diminished efficacy, serious adverse side effects, drug-to-drug interactions, difficult patient compliance, and bacterial resistance. Get the most recent company news and stock data here >>
  • Affymax, Inc. (NASDAQ:AFFY): The shares closed at $5.32, up $0.18, or 3.5%, on the day. Its market capitalization is $190.09 million. About the company: Affymax Inc. is a clinical-stage biopharmaceutical company. The Company develops peptide-based drugs for the treatment of serious and life-threatening conditions such as kidney disease and cancer. Get the most recent company news and stock data here >>
  • Gilead Sciences, Inc. (NASDAQ:GILD): The shares closed at $39.64, up $0.88, or 2.27%, on the day. Its market capitalization is $29.78 billion. About the company: Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company’s primary arees of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions. Get the most recent company news and stock data here >>

Losers (% price change)

  • Delcath Systems, Inc. (NASDAQ:DCTH): The shares closed at $2.37, down $0.25, or 9.54%, on the day. Its market capitalization is $113.75 million. About the company: Delcath Systems Inc. has developed a system to isolate the liver from the circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. This system filters the patients blood removing most of the harmful chemotherapy agents lessening the side-effects of the treatment. Get the most recent company news and stock data here >>
  • Cadence Pharmaceuticals (NASDAQ:CADX): The shares closed at $4.16, down $0.4, or 8.77%, on the day. Its market capitalization is $264.64 million. About the company: Cadence Pharmaceuticals Inc. is a biopharmaceutical company that develops drugs for use in hospitals. The Company produces intravenous APAP for the treatment of acute pain and fever, and omiganan for the prevention of intravascular catheter-related infections. Get the most recent company news and stock data here >>
  • AVANIR Pharmaceuticals (NASDAQ:AVNR): The shares closed at $2.07, down $0.19, or 8.41%, on the day. Its market capitalization is $257.07 million. About the company: AVANIR Pharmaceuticals Inc. develops, acquires, and markets treatments for central nervous system disorders, inflammation, and infectious diseases. Get the most recent company news and stock data here >>
  • Micromet Inc. (NASDAQ:MITI): The shares closed at $5.25, down $0.45, or 7.89%, on the day. Its market capitalization is $483.24 million. About the company: Micromet, Inc. is a biotechnology company. The Company develops novel antibody-based drugs for the treatment of cancer, inflammation and autoimmune diseases. Get the most recent company news and stock data here >>
  • GTx, Inc. (NASDAQ:GTXI): The shares closed at $2.51, down $0.21, or 7.72%, on the day. Its market capitalization is $157.60 million. About the company: GTx, Inc. discovers, develops, and commercializes therapeutics primarily related to the treatment of serious men’s health conditions. The Company’s drug discover and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens, two essential classes of hormones. GTx is currently developing products for prostate cancer. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet